| VDAC1 and the TSPO: expression, interactions, and associated functions in health and disease states V Shoshan-Barmatz, S Pittala, D Mizrachi International journal of molecular sciences 20 (13), 3348, 2019 | 83 | 2019 |
| Targeting liver cancer and associated pathologies in mice with a mitochondrial VDAC1-based peptide S Pittala, Y Krelin, V Shoshan-Barmatz Neoplasia 20 (6), 594-609, 2018 | 63 | 2018 |
| The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target A Verma, S Pittala, B Alhozeel, A Shteinfer-Kuzmine, E Ohana, R Gupta, ... Molecular Therapy 30 (2), 726-744, 2022 | 42 | 2022 |
| A mitochondrial VDAC1-based peptide greatly suppresses steatosis and NASH-associated pathologies in a mouse model S Pittala, Y Krelin, Y Kuperman, V Shoshan-Barmatz Molecular Therapy 27 (10), 1848-1862, 2019 | 35 | 2019 |
| VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism H Klapper-Goldstein, A Verma, S Elyagon, R Gillis, M Murninkas, S Pittala, ... Scientific reports 10 (1), 22101, 2020 | 28 | 2020 |
| Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology A Verma, A Shteinfer-Kuzmine, N Kamenetsky, S Pittala, A Paul, ... Translational Neurodegeneration 11 (1), 58, 2022 | 25 | 2022 |
| The VDAC1-based R-Tf-D-LP4 peptide as a potential treatment for diabetes mellitus S Pittala, I Levy, S De, S Kumar Pandey, N Melnikov, T Hyman, ... Cells 9 (2), 481, 2020 | 19 | 2020 |
| Rewiring of cancer cell metabolism by mitochondrial VDAC1 depletion results in time-dependent tumor reprogramming: Glioblastoma as a proof of concept T Arif, O Stern, S Pittala, V Chalifa-Caspi, V Shoshan-Barmatz Cells 8 (11), 1330, 2019 | 18 | 2019 |
| Ameliorative effect of morin hydrate, a flavonoid against gentamicin induced oxidative stress and nephrotoxicity in sprague-dawley rats VG Jonnalagadda, S Pittala, M Lahkar, V Pradeep International Journal of Pharmacy and Pharmaceutical Sciences 6 (1), 851-856, 2013 | 15 | 2013 |
| The prelude on novel receptor and ligand targets involved in the treatment of diabetes mellitus VG Jonnalagadda, AVSR Raju, S Pittala, A Shaik, NA Selkar Advanced Pharmaceutical Bulletin 4 (3), 209, 2014 | 11 | 2014 |
| Erratum: The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target (Molecular Therapy (2022) 30 (2)(726–744),(S1525001621003543 … A Verma, S Pittala, B Alhozeel, A Shteinfer-Kuzmine, E Ohana, R Gupta, ... Molecular Therapy 32 (4), 1178, 2024 | | 2024 |
| Hepatic GRK2 is dispensable for glucose homeostasis and other key metabolic parameters in mice AB Oteng, S Pittala, A Kliewer, Y Qiu, J Wess Molecular Metabolism 79, 101866, 2024 | | 2024 |
| ACTIVATION OF RECEPTOR-MEDIATED G12 SIGNALING HAS PRONOUNCED EFFECTS ON HEPATIC GLUCOSE FLUXES S Pittala, D Haspula, Y Cui, OP McGuinness, A Inoue, J Wess HEPATOLOGY 78, S1999-S1999, 2023 | | 2023 |
| Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology (vol 11 … A Verma, A Shteinfer-Kuzmine, N Kamenetsky, S Pittala, A Paul, ... TRANSLATIONAL NEURODEGENERATION 12 (1), 2023 | | 2023 |
| Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology A Verma, A Shteinfer-Kuzmine, N Kamenetsky, S Pittala, A Paul, ... Translational Neurodegeneration 12, 2023 | | 2023 |
| Cancer Stem Cells as Therapeutic Targets for Gastrointestinal Cancers JP Mandala, S Pittala, G Srivani Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers …, 2020 | | 2020 |
| Mitochondrial VDAC1 based peptide as a new therapeutic agent for hepatocellular carcinoma S Pittala, Y Krelin, V Shoshan-Barmatz Journal of Hepatology 68, S675, 2018 | | 2018 |
| A VDAC1-based peptide as a therapeutic agent for liver cancer S Pittala, Y Krelin, VS Barmatz FEBS JOURNAL 284, 278-278, 2017 | | 2017 |
Dario MizrachiBrigham Young UniversityVerified email at byu.edu
